Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNFα agents: a French nationwide population-based cohort.

Date publication

octobre 2019

Journal

Alimentary pharmacology & therapeutics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BARDOU Marc , Pr QUANTIN Catherine

Tous les auteurs :
Luu M, Benzenine E, Barkun A, Doret M, Michiels C, Degand T, Quantin C, Bardou M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31617226

Résumé

Children born to mothers with IBD may be exposed to anti-TNFα agents antenatally. Current European guidelines recommend postponing live vaccines until after 6 months of life in this population. Data on the safety of live vaccines administration in the first year of life of these children are sparse with one reported fatality following bacillus Calmette-Guerin (BCG) administration.

Référence

Aliment. Pharmacol. Ther.. 2019 Oct 15;: